Reatul Karim
PHONE

Office: 136

EMAIL

drtk@ewubd.edu

PERSONAL WEB

Dr. Reatul Karim

Assistant Professor
Department of Pharmacy

  • Ph.D. in Biomedical and Pharmaceutical Sciences, University of Liege, Belgium and Ph.D. in Experimental and Clinical Pharmacology, University of Angers, France (Erasmus Mundus Joint Doctorate)
  • M.Res. in Drug Delivery Systems, University of Strathclyde, United Kingdom
  • M.Pharm. in Pharmaceutical Technology, University of Dhaka, Bangladesh
  • B.Pharm. (Hons.), University of Dhaka, Bangladesh
27/10/2009–16/06/2010 Product Development Officer
Novartis Bangladesh Limited, Gazipur (Bangladesh)
15/09/2010–29/04/2012 Lecturer, Dept. of Pharmacy
State University of Bangladesh, Dhaka (Bangladesh)
30/04/2012–28/02/2014 Senior Lecturer, Dept. of Pharmacy
State University of Bangladesh, Dhaka (Bangladesh)
01/03/2014–30/11/2017 Assistant Professor, Dept. of Pharmacy
State University of Bangladesh, Dhaka (Bangladesh)
02/01/2018–Present Assistant Professor, Dept. of Pharmacy
East West University, Dhaka (Bangladesh)
  • Nanosized drug delivery systems development
  • Development and optimization of formulations

Journal Publication

International
  • Karim, R., Lepeltier, E., Esnault, L., Pigeon, P., Lemaire, L., Lépinoux-Chambaud, C., Clere, N., Jaouen, G., Eyer, J., Piel, G. and Passirani, C., 2018. Enhanced and preferential internalization of lipid nanocapsules into human glioblastoma cells: effect of surface-functionalizing NFL peptide. Nanoscale.
  • Karim R, Palazzo C, Laloy J, Delvigne AS, Vanslambrouck S, Jerome C, Lepeltier E, Orange F, Dogne JM, Evrard B, Passirani C. (2017). Development and evaluation of injectable nanosized drug delivery systems for apigenin. International Journal of Pharmaceutics. 532(2), 757-768.
  • Karim, R., Somani, S., Al Robaian, M., Mullin, M., Amor, R., McConnell, G., Dufès, C. (2017). Tumor regression after intravenous administration of targeted vesicles entrapping the vitamin E α-tocotrienol. Journal of Controlled Release, 246, 79-87.
  • Palazzo C, Karim R, Evrard B, Piel G. (2016). Drug delivery nanocarriers to cross of the blood-brain barrier. Nanobiomaterials in drug delivery.
  • Karim R, Palazzo C, Evrard B, Piel G. (2016). Nanocarriers for the treatment of glioblastoma multiforme: current state-of-the-art. Journal of Controlled Release. 227:23-37.
  • Lim LY, Koh PY, Somani S, Al Robaian M, Karim R, Yean YL, Mitchell J, Tate RJ, Edrada-Ebel R, Blatchford DR, Mullin M., Dufes C. (2015). Tumor regression following intravenous administration of lactoferrin-and lactoferricin-bearing dendriplexes. Nanomedicine: Nanotechnology, Biology and Medicine. 11(6):1445-54.
  • Karim, R., Poly, N., Banoo, R. (2012). Development and validation of UV spectroscopic method for the determination of Metformin hydrochloride in tablet dosage form. International Journal of Pharmaceutical Sciences and Research, 3(9), 3170.
National
  1. Khisha, T., Karim, R., Chowdhury, S. R., Banoo, R. (2012). Ethnomedical studies of chakma communities of Chittagong hill tracts, Bangladesh. Bangladesh Pharmaceutical Journal, 15(1), 59-67.
  2. Karim, R., Banoo, R. (2012). Review on NSAIDs: Frequently Used Drugs with Underlying Risks. Bangladesh Pharmaceutical Journal, 15(2), 187-191.

Conference & Seminars

  1. Karim, R et al. (2015). PEGylated liposomes containing apigenin for the treatment of glioblastoma. 1st European Conference on Pharmaceutics: Drug Delivery, Reims, France.
  2. Karim, R et al. (2015). Liposomes entrapping apigenin for the treatment of glioblastoma.  2015 UKICRS Workshop & Symposium, Nottingham, United Kingdom.
  3. Karim, R et al. (2015). Stealth liposome and drug-in-cyclodextrin-in-liposome formulations entrapping apigenin as novel therapy for glioblastoma. UniGR Workshop on Biomedicine: From Drug Target to Drug Development, Arlon, Belgium.
  4. Karim, R et al. (2015). Design of liposomes entrapping apigenin- a novel approach for glioblastoma therapy.  2015 AAPS Annual Meeting and Exposition, Orlando, USA.
  5. Karim, R et al. (2015). Development of apigenin loaded liposomes for glioma treatment.  Meeting of the Belgian-Dutch Biopharmaceutical Society, Leuven, Belgium.
  6. Karim R et al. (2016). Development of injectable liposomes entrapping apigenin for brain-targeted delivery as glioblastoma treatment. 10th World Meeting on Pharmaceutics, Biopharmaceutics and Pharmaceutical Technology, Glasgow, United Kingdom.
  7. Karim R et al. (2016). Development and comparison of liposomes and nanocapsules as injectable nanocarriers for poorly aqueous soluble drugs. Journées annuelles SFNano 2016, Paris, France.
  8. Karim R et al. (2017). Lipid nanocapsule internalization in U87MG human glioblastoma cells: effect of surface-functionalizing FAM-NFL.TBS-40.63 peptide concentration. 3rd CDT in Advanced Therapeutics and Nanomedicines School/5th NanoFar School, Nottingham, United Kingdom.
  9. Karim, R et al. (2017). Enhancement of the internalization of lipid nanocapsules in human glioblastoma cells: Effect of surface concentration of NFL peptide. 11èmes Journées du Cancéropôle Grand Ouest, Vannes, France.
  10. Karim, R et al. (2017). Enhanced internalization of lipid nanocapsules in human glioblastoma cells: Influence of the concentration of surface-functionalizing NFL peptide. 21st International Symposium on Microencapsulation, Faro, Portugal.
  11. Karim R et al. (2017). Lipid nanocapsules entered preferentially into human glioblastoma cells compared to normal human astrocytes after surface-functionalization with NFL-TBS.40-63 peptide: in vitro and preliminary in vivo studies. 4th Annual Meeting SFNano, Bordeaux, France.

Other

Publications will be here.

+ Academic Background
  • Ph.D. in Biomedical and Pharmaceutical Sciences, University of Liege, Belgium and Ph.D. in Experimental and Clinical Pharmacology, University of Angers, France (Erasmus Mundus Joint Doctorate)
  • M.Res. in Drug Delivery Systems, University of Strathclyde, United Kingdom
  • M.Pharm. in Pharmaceutical Technology, University of Dhaka, Bangladesh
  • B.Pharm. (Hons.), University of Dhaka, Bangladesh
+ Professional Experience
27/10/2009–16/06/2010 Product Development Officer
Novartis Bangladesh Limited, Gazipur (Bangladesh)
15/09/2010–29/04/2012 Lecturer, Dept. of Pharmacy
State University of Bangladesh, Dhaka (Bangladesh)
30/04/2012–28/02/2014 Senior Lecturer, Dept. of Pharmacy
State University of Bangladesh, Dhaka (Bangladesh)
01/03/2014–30/11/2017 Assistant Professor, Dept. of Pharmacy
State University of Bangladesh, Dhaka (Bangladesh)
02/01/2018–Present Assistant Professor, Dept. of Pharmacy
East West University, Dhaka (Bangladesh)
+ Research Interest
  • Nanosized drug delivery systems development
  • Development and optimization of formulations
+ Selected Publications

Journal Publication

International
  • Karim, R., Lepeltier, E., Esnault, L., Pigeon, P., Lemaire, L., Lépinoux-Chambaud, C., Clere, N., Jaouen, G., Eyer, J., Piel, G. and Passirani, C., 2018. Enhanced and preferential internalization of lipid nanocapsules into human glioblastoma cells: effect of surface-functionalizing NFL peptide. Nanoscale.
  • Karim R, Palazzo C, Laloy J, Delvigne AS, Vanslambrouck S, Jerome C, Lepeltier E, Orange F, Dogne JM, Evrard B, Passirani C. (2017). Development and evaluation of injectable nanosized drug delivery systems for apigenin. International Journal of Pharmaceutics. 532(2), 757-768.
  • Karim, R., Somani, S., Al Robaian, M., Mullin, M., Amor, R., McConnell, G., Dufès, C. (2017). Tumor regression after intravenous administration of targeted vesicles entrapping the vitamin E α-tocotrienol. Journal of Controlled Release, 246, 79-87.
  • Palazzo C, Karim R, Evrard B, Piel G. (2016). Drug delivery nanocarriers to cross of the blood-brain barrier. Nanobiomaterials in drug delivery.
  • Karim R, Palazzo C, Evrard B, Piel G. (2016). Nanocarriers for the treatment of glioblastoma multiforme: current state-of-the-art. Journal of Controlled Release. 227:23-37.
  • Lim LY, Koh PY, Somani S, Al Robaian M, Karim R, Yean YL, Mitchell J, Tate RJ, Edrada-Ebel R, Blatchford DR, Mullin M., Dufes C. (2015). Tumor regression following intravenous administration of lactoferrin-and lactoferricin-bearing dendriplexes. Nanomedicine: Nanotechnology, Biology and Medicine. 11(6):1445-54.
  • Karim, R., Poly, N., Banoo, R. (2012). Development and validation of UV spectroscopic method for the determination of Metformin hydrochloride in tablet dosage form. International Journal of Pharmaceutical Sciences and Research, 3(9), 3170.
National
  1. Khisha, T., Karim, R., Chowdhury, S. R., Banoo, R. (2012). Ethnomedical studies of chakma communities of Chittagong hill tracts, Bangladesh. Bangladesh Pharmaceutical Journal, 15(1), 59-67.
  2. Karim, R., Banoo, R. (2012). Review on NSAIDs: Frequently Used Drugs with Underlying Risks. Bangladesh Pharmaceutical Journal, 15(2), 187-191.

Conference & Seminars

  1. Karim, R et al. (2015). PEGylated liposomes containing apigenin for the treatment of glioblastoma. 1st European Conference on Pharmaceutics: Drug Delivery, Reims, France.
  2. Karim, R et al. (2015). Liposomes entrapping apigenin for the treatment of glioblastoma.  2015 UKICRS Workshop & Symposium, Nottingham, United Kingdom.
  3. Karim, R et al. (2015). Stealth liposome and drug-in-cyclodextrin-in-liposome formulations entrapping apigenin as novel therapy for glioblastoma. UniGR Workshop on Biomedicine: From Drug Target to Drug Development, Arlon, Belgium.
  4. Karim, R et al. (2015). Design of liposomes entrapping apigenin- a novel approach for glioblastoma therapy.  2015 AAPS Annual Meeting and Exposition, Orlando, USA.
  5. Karim, R et al. (2015). Development of apigenin loaded liposomes for glioma treatment.  Meeting of the Belgian-Dutch Biopharmaceutical Society, Leuven, Belgium.
  6. Karim R et al. (2016). Development of injectable liposomes entrapping apigenin for brain-targeted delivery as glioblastoma treatment. 10th World Meeting on Pharmaceutics, Biopharmaceutics and Pharmaceutical Technology, Glasgow, United Kingdom.
  7. Karim R et al. (2016). Development and comparison of liposomes and nanocapsules as injectable nanocarriers for poorly aqueous soluble drugs. Journées annuelles SFNano 2016, Paris, France.
  8. Karim R et al. (2017). Lipid nanocapsule internalization in U87MG human glioblastoma cells: effect of surface-functionalizing FAM-NFL.TBS-40.63 peptide concentration. 3rd CDT in Advanced Therapeutics and Nanomedicines School/5th NanoFar School, Nottingham, United Kingdom.
  9. Karim, R et al. (2017). Enhancement of the internalization of lipid nanocapsules in human glioblastoma cells: Effect of surface concentration of NFL peptide. 11èmes Journées du Cancéropôle Grand Ouest, Vannes, France.
  10. Karim, R et al. (2017). Enhanced internalization of lipid nanocapsules in human glioblastoma cells: Influence of the concentration of surface-functionalizing NFL peptide. 21st International Symposium on Microencapsulation, Faro, Portugal.
  11. Karim R et al. (2017). Lipid nanocapsules entered preferentially into human glioblastoma cells compared to normal human astrocytes after surface-functionalization with NFL-TBS.40-63 peptide: in vitro and preliminary in vivo studies. 4th Annual Meeting SFNano, Bordeaux, France.

Other

Publications will be here.